Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13988190 | 0.95 | ALK (0.33) | ALKPDK2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL8510608 | 0.94 | MEN1 (0.32) | ALKHTTGPR84PDK2RECQL | |
| SCHEMBL15214880 | 0.93 | CHRNB4 (0.32) | ALKPDK2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL13988163 | 0.92 | PDK2 (0.32) | ALKPDK2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL13988246 | 0.92 | ALK (0.40) | ALKGPR84PDK2 | |
| SCHEMBL29664189 | 0.92 | RECQL (0.33) | HTTPDK2RECQL | |
| SCHEMBL9929431 | 0.92 | RECQL (0.33) | HTTPDK2RECQL | |
| SCHEMBL30708919 | 0.92 | MEN1 (0.31) | ALKHTTPDK2RECQL | |
| SCHEMBL1823143 | 0.92 | ALK (0.35) | ALKGPR84PDK2 | |
| SCHEMBL3704719 | 0.92 | MEN1 (0.31) | ALKHTTPDK2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2545095-B1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL INC (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-2545140-B1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | TRANSITIONS OPTICAL INC (US) | 2017-06-21 | — | — | EP | disclosed |
| US-8647538-B2 | Photochromic compounds having at least two photochromic moieties | TRANSITIONS OPTICAL, INC. (US) | 2014-02-11 | — | — | US | disclosed |
| US-8563213-B2 | Methods for producing photosensitive microparticles | TRANSITIONS OPTICAL, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| US-8563212-B2 | Methods for producing photosensitive microparticles, non-aqueous dispersions thereof and articles prepared therewith | TRANSITIONS OPTICAL, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| EP-2545140-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | Transitions Optical, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| EP-2545095-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | Transitions Optical, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| US-20120136148-A1 | Photochromic Compounds Having At Least Two Photochromic Moieties | TRANSITIONS OPTICAL, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2011112327-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| WO-2011112325-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20100221661-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100209697-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL, INC. (US) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136148-A1 | Photochromic Compounds Having At Least Two Photochromic Moieties | CRY2, PCNA, MTCL3 | ALK 3290/4885HTT 149/4885GPR84 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.